Browse > Article
http://dx.doi.org/10.3904/kjm.2012.82.2.236

A Case of Rifampin-Induced Crescentic Glomerulonephritis  

Lee, Kyung-Nam (Department of Internal Medicine, Pusan National University School of Medicine)
Song, Sang-Heon (Department of Internal Medicine, Pusan National University School of Medicine)
Rhee, Ha-Rin (Department of Internal Medicine, Pusan National University School of Medicine)
Seong, Eun-Young (Department of Internal Medicine, Pusan National University School of Medicine)
Kim, Il-Young (Department of Internal Medicine, Pusan National University School of Medicine)
Lee, Soo-Bong (Department of Internal Medicine, Pusan National University School of Medicine)
Kwak, Ihm-Soo (Department of Internal Medicine, Pusan National University School of Medicine)
Publication Information
The Korean Journal of Medicine / v.82, no.2, 2012 , pp. 236-240 More about this Journal
Abstract
A 56-year-old male with pulmonary tuberculosis was admitted to our hospital for evaluation of generalized edema. He began antituberculosis treatment with rifampin, isoniazid, ethambutol, and pyrazinamide. He experienced abnormal increments in weight and serum creatinine after 6 weeks. All serological findings, including anti-neutrophil cytoplasmic antibodies (ANCA), were negative. Rifampin was stopped because it might have caused the increase in creatinine. Renal biopsy was consistent with pauci-immune crescentic glomerulonephritis (CrGN). His renal function was improved by high-dose steroid treatment. Rifampin-induced, ANCA-negative pauci-immune CrGN is very rare; most cases of rifampin-induced acute renal failure are due to acute tubulointerstitial nephritis. We present here a case of rifampin-induced CrGN and pulmonary tuberculosis successfully treated with high-dose steroids and antituberculosis medications, excluding rifampin.
Keywords
Rifampin; Anti-neutrophil cytoplasmic antibodies; Glomerulonephritis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003;63:1164-1177.   DOI
2 Lim CS, Jung YC, Lee SG, et al. Rifampin induced rapidly progressive glomerulonephritis. Korean J Nephrol 1998;17: 503-509.
3 Hirsch DJ, Bia FJ, Kashgarian M, Bia MJ. Rapidly progressive glomerulonephritis during antituberculous therapy. Am J Nephrol 1983;3:7-10.   DOI
4 Murray AN, Cassidy MJ, Templecamp C. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis. Nephron 1987;46:373-376.   DOI
5 Wen YK, Chen ML. Crescentic glomerulonephritis associated with rifampicin in a patient co-infected with tuberculosis and human immunodeficiency virus. Clin Nephrol 2006;65: 284-249.   DOI
6 Kohler LJ, Gohara AF, Hamilton RW, Reeves RS. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis. Clin Nephrol 1994;42:263-265.
7 Ogata H, Kubo M, Tamaki K, Hirakata H, Okuda S, Fujishima M. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis. Nephron 1998;78:319-322.   DOI
8 Moon SC, Park HK, Kwak IS, Shin YW, Shin YK. A case of acute renal failure due to rifampion. Korean J Med 1981; 24:1237-1241.
9 Yoshioka K, Satake N, Kasamatsu Y, Nakamura Y, Shikata N. Rapidly progressive glomerulonephritis due to rifampicin therapy. Nephron 2002;90:116-118.   DOI